How One CEO Is Changing Life Sciences Innovation
Using a unique company incubator approach, Paragon Biosciences boasts an 80%–90% approval rate on new drug applications, far exceeding that of the traditional pharma industry.
Using a unique company incubator approach, Paragon Biosciences boasts an 80%–90% approval rate on new drug applications, far exceeding that of the traditional pharma industry.
Chief Executive Group exists to improve the performance of U.S. CEOs, senior executives and public-company directors, helping you grow your companies, build your communities and strengthen society. Learn more at chiefexecutivegroup.com.
0